Search

Background A proportion of phenotypic type 2 diabetes (T2D) patients produce pancreatic autoantibodies and a majority of T2D patients develop serious life-disabling complications over time despite the implementation of adequate clinical interventions. This study determined whether the presence of pancreatic autoantibodies (GADA, IA-2A, anti-ZnT8, or ICA) was associated with serious complications or concomitant diseases of adult patients diagnosed with T2D (N = 305). Main results In the study population, 22·3% (N = 68) of subjects were positive for at least 1 of the 4 of the markers associated with autoimmune diabetes (presence of pancreatic autoantibody – pAb), followed by GADA (14·1%, N = 43), ICA (8·9%, N = 27), anti-ZnT8 (5·6%, N = 17) and IA-2A (2·0%, N = 6). Logistic regression analysis adjusted for patient's age, gender and duration of T2D revealed that (i) pAb was associated with higher prevalence of adiposity (odds ratio of adjusted regression model (adOR) 2·51, P = 0·032); (ii) pAb, GADA and anti-ZnT8 were associated with autoimmune thyroid disease (adORs 3·07, P = 0·012; 6·29, P

Immune responses to neuronal proteins are a frequent occurrence in neurodegenerative diseases. This study determines the occurrence of autoantibodies to the three neurofilament subunits in phosphorylated and dephosphorylated forms and relates these measures to age, human leukocyte antigen (HLA), and severity of disease in Down syndrome (DS). IgG-type antibodies to three neurofilament (NF) subunits, NF-L, NF-M, and NF-H, in both phosphorylated and dephosphorylated forms were tested by immunoblot in 128 patients with DS and compared to antibody levels in 94 normal controls. DS was revealed by karyotype analysis. Antibodies to dephospho-NF-M, NF-M, and NF-L were more common in DS samples than in controls. Total pools of DS and control samples had similar frequency of antibodies to NF-H, but there was a higher prevalence of antibodies against NF-H in DS patients with moderate or mild disability (43.0%) compared with those having serious disability (14.3%). No NF-H antibody was seen among young children (age 14 years or younger) of the latter group. The HLA-DR15 allele was negatively correlated with antibodies against NF-H. The high prevalence of antibodies to neurofilament proteins and the differences between DS and control samples may reflect the cross-talk between neural and immune systems that could have an important role in defending neural structures from neurodegenerative processes. In children with DS the presence of antibodies to NF-H might reflect a more favorable prognosis.